Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study.
Bin Abdulhak AA, Altannir MA, Almansor MA, Almohaya MS, Onazi AS, Marei MA, Aldossary OF, Obeidat SA, Obeidat MA, Riaz MS, Tleyjeh IM. Bin Abdulhak AA, et al. Among authors: marei ma. BMC Public Health. 2011 Jul 7;11:538. doi: 10.1186/1471-2458-11-538. BMC Public Health. 2011. PMID: 21736711 Free PMC article.
Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
Motabi IH, Aoun SMA, Al-Ammari M, Albtoosh BM, Iqbal S, Altaf SY, Tailor IK, Alnoamani MS, AlGhamdi MS, Zaidi SZ, AlShehry NF, Marei MA, Alfayez M. Motabi IH, et al. Among authors: marei ma. Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):720-723. doi: 10.1016/j.clml.2021.07.019. Epub 2021 Jul 29. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34417161 Clinical Trial. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 32950467
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice.
Aleem A, Shaheen NA, Algahtani F, Jamal A, Alkhudair N, Alghafis M, Iqbal Z, Siti HWZ, Thomas A, Alahmari B, Salama H, Gmati G, Alzahrani M, Alhejazi A, Alfayez M, Alrajhi A, Marei MA, Alaskar A. Aleem A, et al. Among authors: marei ma. Clin Lymphoma Myeloma Leuk. 2024 Aug 24:S2152-2650(24)00310-0. doi: 10.1016/j.clml.2024.08.006. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39299826